NCT07292597

Brief Summary

This study examines how a person's natural daily rhythm ("chronotype") affects the way time is experienced and judged. Healthy Danish-speaking adults (23-45 years) who are clearly morning-type or evening-type will complete two lab sessions in a crossover design: one at their preferred time of day (e.g., morning for morning-types) and one at the opposite time (misaligned). In each session, participants do brief computerized tasks that measure time estimation/production, vigilance (psychomotor vigilance task), decision-making, and responses to social information, plus simple color-vision tasks. Short questionnaires about sleepiness, mood, fatigue, and the subjective "passage of time" are collected before, during, and after testing. A subset will wear a wrist actigraphy device for one week beforehand to characterize sleep-wake patterns. Testing is conducted under standardized lab conditions with scheduled breaks. The main goal is to determine whether time judgments and vigilance are less accurate during the misaligned session and whether decision-making and social responses also vary with circadian timing. Risks are minimal and mainly relate to temporary tiredness when tested at a non-preferred time; participants may stop at any time. Participation is voluntary. Data are pseudonymized and handled under GDPR. Participants receive DKK 300 after completing both sessions (pro-rated if they withdraw early). Results will be published regardless of outcome, and de-identified data/code will be shared after publication.This study examines how a person's natural daily rhythm ("chronotype") affects the way time is experienced and judged. Healthy Danish-speaking adults (23-45 years) who are clearly morning-type or evening-type will complete two lab sessions in a crossover design: one at their preferred time of day (e.g., morning for morning-types) and one at the opposite time (misaligned). In each session, participants do brief computerized tasks that measure time estimation/production, vigilance (psychomotor vigilance task), decision-making, and responses to social information, plus simple color-vision tasks. Short questionnaires about sleepiness, mood, fatigue, and the subjective "passage of time" are collected before, during, and after testing. A subset will wear a wrist actigraphy device for one week beforehand to characterize sleep-wake patterns. Testing is conducted under standardized lab conditions with scheduled breaks. The main goal is to determine whether time judgments and vigilance are less accurate during the misaligned session and whether decision-making and social responses also vary with circadian timing. Risks are minimal and mainly relate to temporary tiredness when tested at a non-preferred time; participants may stop at any time. Participation is voluntary. Data are pseudonymized and handled under GDPR. Participants receive DKK 300 after completing both sessions (pro-rated if they withdraw early). Results will be published regardless of outcome, and de-identified data/code will be shared after publication.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
128

participants targeted

Target at P50-P75 for not_applicable

Timeline
13mo left

Started Oct 2025

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress32%
Oct 2025Jun 2027

Study Start

First participant enrolled

October 25, 2025

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

November 14, 2025

Completed
1 month until next milestone

First Posted

Study publicly available on registry

December 18, 2025

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2027

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2027

Last Updated

December 22, 2025

Status Verified

October 1, 2025

Enrollment Period

1.5 years

First QC Date

November 14, 2025

Last Update Submit

December 19, 2025

Conditions

Keywords

chronotypecircadian misalignmentduration discriminationtime productiontime estimation

Outcome Measures

Primary Outcomes (1)

  • Time estimation bias

    Signed percent error across 10, 30, and 60 s trials with a fixation cross: ((estimated - target)/target) × 100. Three trials per duration; session-level mean computed. Primary contrast: incongruent - congruent (within-subject). Higher values = overestimation.

    Day 1 (once during each of the two laboratory sessions: morning and evening)

Secondary Outcomes (6)

  • Psychomotor Vigilance Task (PVT) lapses (count)

    Day 1 (once during each of the two laboratory sessions: morning and evening)

  • Time production bias (neutral stimuli, 10-60 s)

    Day 1 (once during each of the two laboratory sessions: morning and evening)

  • Duration discrimination threshold (2AFC adaptive)

    Day 1 (once during each of the two laboratory sessions: morning and evening)

  • Subjective passage-of-time rating (VAS 0-100)

    Day 1 (pre-, mid-, and post-session ratings during each of the two laboratory sessions)

  • Decision-making exploration rate (%) - Alien Game

    Day 1 (once during each of the two laboratory sessions: morning and evening)

  • +1 more secondary outcomes

Study Arms (2)

Sequence AB - Congruent → Incongruent

EXPERIMENTAL

rossover sequence AB. Participants first complete a circadian-congruent session (morning types in the morning; evening types in the evening), followed by a circadian-incongruent session (opposite time). Intervention administered: Behavioral - Session timing relative to chronotype.

Behavioral: Session timing relative to chronotype

Sequence BA - Incongruent → Congruent

EXPERIMENTAL

Crossover sequence BA. Participants first complete a circadian-incongruent session (opposite of their preferred time), then a circadian-congruent session. Intervention administered: Behavioral - Session timing relative to chronotype.

Behavioral: Session timing relative to chronotype

Interventions

Two-period, two-sequence crossover manipulation of testing time. Each participant completes both sessions: (1) circadian-congruent timing (morning types tested in the morning; evening types in the evening) and (2) circadian-incongruent timing (opposite time). Session order is randomized (AB/BA). Sessions are run morning and evening on the same day with a substantial interval; no visible clocks; 12-h pre-session caffeine/strenuous-exercise restriction; standardized lab light/temperature. Primary outcomes: time-estimation/production bias and PVT lapses/RT.

Also known as: Circadian alignment, Circadian misalignment, Timing condition
Sequence AB - Congruent → IncongruentSequence BA - Incongruent → Congruent

Eligibility Criteria

Age23 Years - 45 Years
Sexall(Gender-based eligibility)
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • Aged 23 to 45 years
  • Able to understand and communicate in Danish
  • Completed at least upper secondary education (e.g., gymnasium)
  • Categorized as either a Morning Type (MT) or Evening Type (ET) based on standardized chronotype assessments:
  • Munich Chronotype Questionnaire (MCTQ):
  • MT: sleep midpoint on free days (MSFsc) ≤ 03:00
  • ET: sleep midpoint on free days (MSFsc) ≥ 05:00
  • Morningness-Eveningness Questionnaire (MEQ):
  • One of four defined chronotype categories (definitely morning, moderately morning, moderately evening, definitely evening).

You may not qualify if:

  • Current engagement in shift work, rotating schedules, or other forms of irregular sleep-wake timing
  • Diagnosis of any neurological, psychiatric, or sleep-related disorder (e.g., insomnia, narcolepsy, sleep apnea)
  • Use of medications that affect sleep, alertness, or circadian functioning (e.g., melatonin, stimulants, antidepressants)
  • International travel across time zones within the four weeks preceding study participation
  • Are classified as having an intermediate chronotype based on validated chronotype assessments (MCTQ or MEQ), as this group does not provide the necessary contrast to evaluate circadian alignment effects.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cognition and Behavior Lab

Aarhus, 8000, Denmark

RECRUITING

Central Study Contacts

Ali Amidi, PhD

CONTACT

Cehao Yu, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
CROSSOVER
Model Details: Two-period, two-sequence (AB/BA) crossover. Each participant completes both sessions: circadian-congruent timing and circadian-incongruent timing. Session order is randomized; sessions occur morning and evening on the same day with a substantial interval and standardized pre-session restrictions.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 14, 2025

First Posted

December 18, 2025

Study Start

October 25, 2025

Primary Completion (Estimated)

April 30, 2027

Study Completion (Estimated)

June 30, 2027

Last Updated

December 22, 2025

Record last verified: 2025-10

Locations